IndiaMTF — home
Stock

SMS Pharmaceuticals — MTF Book

SMSPHARMA · SMS Pharmaceuticals Limited
Health Technology

Daily Margin Trading Facility book for SMS Pharmaceuticals across NSE and BSE, from 04 Aug 2017. All figures in ₹ crore, derived from exchange public disclosures.

What is SMS Pharmaceuticals’s MTF book?

SMS Pharmaceuticals Limited (SMSPHARMA) has ₹48 crore funded under Margin Trading Facility across NSE and BSE as of 26 Oct 2026 — 0.03% of India’s MTF book, ranking #660. Over 1M (the last 30 trading days) the funded value has risen 21.6%, with the number of shares under margin up 12.9%.

Funded value
₹48 Cr
as of 26 Oct 2026
Rank in book
#660
1,042 days tracked
Share of book
0.03%
of the whole NSE + BSE book
Peak funded
₹59 Cr
on 17 Sep 2026
Largest single-day addition
+₹15 Cr
on 15 Sep 2026
Largest single-day unwind
−₹5 Cr
on 21 Sep 2026
Free-float market cap
₹1,250 Cr
full market cap ₹3,913 Cr · 31.9% free float · Small cap
MTF share of free float
3.83%
1.8× the median small cap · 4.6× the Health Technology median

Share of free float on margin, month by month

Shares under margin at each month-end as a share of free-float shares, using that month-end’s share count and the free-float filing public at the time. It counts shares, not value, so a price move does not move it by itself.

0.87%2.04%3.22%4.39%Jan 2025Oct 2026
View as table: share of free float on margin21 months
Month-end% of free float
26 Oct 20263.829%
30 Sep 20263.984%
31 Aug 20262.521%
31 Jul 20262.135%
30 Jun 20261.725%
29 May 20261.988%
30 Apr 20261.595%
30 Mar 20261.277%
05 Jan 2026†1.623%
29 Dec 2025†1.623%
25 Nov 2025†1.731%
31 Oct 20251.748%
30 Sep 20251.490%
19 Aug 2025†1.303%
31 Jul 20251.372%
30 Jun 20251.542%
30 May 20251.572%
30 Apr 20251.790%
28 Mar 20252.229%
28 Feb 20251.954%
31 Jan 20251.774%

† Not the month’s last trading day: the last day the stock was in the archive that month (before 11 Nov 2025 the archive kept only the 500 largest positions).

Dated events

NSE & BSE split

How SMSPHARMA’s funded book divides across the two exchanges, as of 26 Oct 2026.
NSE
NSE ₹46 Cr · 96.9%BSE ₹2 Cr · 3.1%

MTF vs Price

Margin-funded outstanding for SMSPHARMA in ₹ crore against the closing price, adjusted for splits and bonuses. Each window uses the same reference date as the table below, so the two agree. Funded value moves with the price on its own, so the line under the chart reads the share count instead — that is what shows whether more stock is genuinely being borrowed against.
MTF book (₹ Cr)

Price and liquidity

Adjusted for splits and bonuses, so a change across a corporate action reflects the market rather than the share count.
Last close
₹414.60
as of 23 Oct 2026
Price, 1M
+1.8%
adjusted for splits and bonuses
Delivery, 20-day avg
44.5%
of traded volume actually settled
Sessions to unwind
7
of average deliverable volume
Shares under margin divided by average daily deliverable volume over the last 20 sessions.

Book, shares and price by window

Funded value moves with the price on its own, so the share count is what shows whether more stock is actually being borrowed against. The last column reads the two together.
WindowBook ΔBook %SharesPriceReading
1D+₹0+0.4%+0.8%
+9,017
+0.0%building as it falls
10D−₹2−3.4%−2.2%
−25,416
−6.8%unwinding as it falls
1M+₹8+21.6%+12.9%
+1,31,107
+1.8%building into strength
3M+₹26+120.7%+103.6%
+5,82,763
+8.8%building into strength
6M+₹31+181.8%+151.0%
+6,88,830
+4.5%building into strength
1Ynot enough history

Shares under margin

Number of shares funded via MTF over time (NSE + BSE combined).

Rank trajectory

Where SMSPHARMA has sat in the funded-value ranking each day (1 = most funded). Lower is more prominent.

SMSPHARMA — last 30 trading days

Combined NSE + BSE funded value, day-on-day change, share of the whole book, and rank. Newest first.
DateCombined (₹ Cr)Day Δ (₹ Cr)% of bookRank
26 Oct 202648+₹00.03%660
23 Oct 202648+₹10.03%665
22 Oct 202647−₹00.03%688
21 Oct 202647−₹10.03%688
19 Oct 202648−₹00.03%674
16 Oct 202649−₹00.03%674
15 Oct 202649−₹10.03%671
14 Oct 202650−₹20.03%662
13 Oct 202652+₹10.03%648
12 Oct 202651+₹10.03%656
09 Oct 202650+₹10.03%661
08 Oct 202648+₹20.03%677
07 Oct 202646−₹00.03%696
06 Oct 202647−₹10.03%688
05 Oct 202647−₹10.03%687
01 Oct 202648−₹20.03%680
30 Sep 202650−₹00.03%666
29 Sep 202650−₹10.03%666
28 Sep 202651+₹10.03%651
25 Sep 202650−₹20.03%661
24 Sep 202652+₹20.03%645
23 Sep 202651−₹10.03%651
22 Sep 202652−₹20.03%647
21 Sep 202654−₹50.04%622
18 Sep 202659−₹00.04%589
17 Sep 202659+₹10.04%586
16 Sep 202658+₹00.04%587
15 Sep 202657+₹150.04%598
11 Sep 202642+₹20.03%725
10 Sep 202640—0.03%747

SMSPHARMA within Health Technology

Ranked #32 of 61 funded Health Technology stocks, carrying 0.7% of that sector’s margin book. Its 3.83% of free float on margin is 4.3× the sector median of 0.89%. Nearest names by funded value:
#StockMTF book (₹ Cr)% of sector% of free floatBook, 1M
30GLENMARKGlenmark Pharmaceuticals₹490.7%0.14%−6.9%
31INDSWFTLABInd-Swift Laboratories₹480.7%3.25%+32.1%
32SMSPHARMASMS Pharmaceuticals₹480.7%3.83%+21.6%
33SUPRIYASupriya Lifescience₹480.7%2.10%−1.8%
34SOLARASolara Active Pharma Sciences₹470.7%2.53%+25.3%

All Health Technology stocks and how the sector has moved →

Disclaimer. Data sourced from daily margin trading disclosure provided by NSE and BSE. This website and page are meant for educational and information only — not investment advice. MTF is leveraged and can amplify losses. Rules, margins, rates and eligible-stock lists change; verify current details with your broker and SEBI/exchange circulars. IndiaMTF.com is not a SEBI-registered intermediary, broker, or investment adviser and has no affiliation with SEBI, NSE or BSE. Figures are reproduced from publicly disclosed exchange data, may be delayed or revised, and should be independently verified before any trading decision. Consult a SEBI-registered investment adviser before investing.